ILC3-derived acetylcholine promotes protease-driven allergic lung pathology - 05/04/21

| Supported by research funding from the Biotechnology and Biological Sciences Research Council (BBSRC, grant BB/R015856/1), Royal Society International Exchange (grant IES∖R1∖180108), Le Studium-Marie Curie Fellowship, European Regional Development fund (FEDER No 2016-00110366 and EX005756); the NRF (SA) Competitive Support for Rated Researchers (grant 111815), Carnegie Corporation of New York DEAL Fellowship, and the National Research Foundation (SA) (grant 99610). The Wellcome Centre for Infectious Disease Research in Africa is supported by core funding from the Wellcome Trust (grant 203135/Z/16/Z). |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
Vol 147 - N° 4
P. 1513 - avril 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
